Expanding Germline Analyses to Prevent and Treat Cancers
-
Precision medicine targets actionable mutations in tumors to appropriate therapies, but finding those mutations can be a challenge. A new approach developed at Memorial Sloan Kettering (MSK) Cancer Center, New York City, which includes a germline mutation analysis, finds more of them.
-
@sangeeta The conventional way of assessing cancer risk will not detect a significant proportion of inherited mutations that are clinically actionable